ANORMED

AnorMED, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic drugs for the treatment of hematology, human immunodeficiency virus (HIV), and oncology. Its lead drug product candidate include MOZOBIL, which is under phase III clinical trial is used for cancer patients undergoing stem cell transplantation; and AMD070, which is under phase Ib/IIa trial is used as a HIV entry inhibitor.

#SimilarOrganizations #More

ANORMED

Industry:
Biotechnology Pharmaceutical

Founded:
1996-01-01

Address:
Langley, British Columbia, Canada

Country:
Canada

Status:
Active

Contact:
(604) 530-1057


Similar Organizations

amylin-pharmaceuticals-logo

Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs.

dyax-logo

Dyax

Dyax Corp. (Dyax) is a biopharmaceutical company focused on the discovery, development and commercialization of biotherapeutics for unmet

not_available_image

Ercole Biotech

Ercole Biotech, Inc., a research stage biopharmaceutical company, creates oligonucleotide drugs that achieve their therapeutic effect by

novel-laboratories-logo

Novel Laboratories

Novel Laboratories a pharmaceutical company, engages in the research, development, and manufacture of generic and branded products.

nutra-pharma-logo

Nutra Pharma

Nutra Pharma Corp., a biopharmaceutical company, engages in the acquisition, licensing, and commercialization of pharmaceutical products

synthemed-logo

SyntheMed

SyntheMed is a biomaterials company engaged in the development and commercialization of medical devices for therapeutic applications.

More informations about "AnorMED" on Search Engine